F2G Announces $70 Million Financing to Advance Development and Commercialization of New Antifungal Agent Olorofim

Corporate Breaking News

Home : F2G Announces $70 Million Financing to Advance Development and Commercialization of New Antifungal Agent Olorofim

Aug 04 2022	F2G Announces $70 Million Financing to Advance Development and Commercialization of New Antifungal Agent Olorofim
New Investment from Forbion and Sofinnova Partners MANCHESTER, England, Aug. 4, 2022 /PRNewswire/ -- F2G Ltd, a clinical-stage biopharmaceutical company focused on the discovery and development of novel therapies to treat life-threatening rare fungal infections with a high unmet medical...


Source:https://www.prnewswire.com:443/news-releases/f2g-announces-70-million-financing-to-advance-development-and-commercialization-of-new-antifungal-agent-olorofim-301599295.html

Related News
» China Issues New Professional Track and Field Clothing Standard » Grünenthal to license osteoarthritis pain treatment to Shionogi in Japan in deal of up to > $ 500 million